PASSALACQUA, MARIA ILENIA
PASSALACQUA, MARIA ILENIA
Dipartimento di Patologia Umana dell'adulto e dell'età evolutiva "Gaetano Barresi"
'Why is survival with triple negative breast cancer so low? insights and talking points from preclinical and clinical research'
2022-01-01 Passalacqua, Maria Ilenia; Rizzo, Graziella; Santarpia, Mariacarmela; Curigliano, Giuseppe
Enfortumab Vedotin in metastatic bladder cancer: a case report of durable clinical efficacy in a pretreated patient
2023-01-01 Passalacqua, Maria Ilenia; Squeri, Andrea; Sciumè, Calogero; Ieni, Antonio; Santarpia, Mariacarmela
Immunotherapeutic Advances for NSCLC
2021-01-01 Massafra, Marco; Passalacqua, Maria Ilenia; Gebbia, Vittorio; Macrì, Paolo; Lazzari, Chiara; Gregorc, Vanesa; Buda, Carmelo; Altavilla, Giuseppe; Santarpia, Mariacarmela
Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives
2023-01-01 Lazzari, Chiara; Spagnolo, Calogera Claudia; Ciappina, Giuliana; Di Pietro, Martina; Squeri, Andrea; Passalacqua, Maria Ilenia; Marchesi, Silvia; Gregorc, Vanesa; Santarpia, Mariacarmela
Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review
2023-01-01 Santarpia, Mariacarmela; Ciappina, Giuliana; Spagnolo, Calogera Claudia; Squeri, Andrea; Passalacqua, Maria Ilenia; Aguilar, Andrés; Gonzalez-Cao, Maria; Giovannetti, Elisa; Silvestris, Nicola; Rosell, Rafael
Therapeutic strategies for HER2-positive breast cancer with central nervous system involvement: a literature review and future perspectives
2023-01-01 Passalacqua, Maria Ilenia; Ciappina, Giuliana; Di Pietro, Martina; Spagnolo, Calogera Claudia; Squeri, Andrea; Granata, Barbara; Muscolino, Paola; Santarpia, Mariacarmela
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 'Why is survival with triple negative breast cancer so low? insights and talking points from preclinical and clinical research' | 1-gen-2022 | Passalacqua, Maria Ilenia; Rizzo, Graziella; Santarpia, Mariacarmela; Curigliano, Giuseppe | |
| Enfortumab Vedotin in metastatic bladder cancer: a case report of durable clinical efficacy in a pretreated patient | 1-gen-2023 | Passalacqua, Maria Ilenia; Squeri, Andrea; Sciumè, Calogero; Ieni, Antonio; Santarpia, Mariacarmela | |
| Immunotherapeutic Advances for NSCLC | 1-gen-2021 | Massafra, Marco; Passalacqua, Maria Ilenia; Gebbia, Vittorio; Macrì, Paolo; Lazzari, Chiara; Gregorc, Vanesa; Buda, Carmelo; Altavilla, Giuseppe; Santarpia, Mariacarmela | |
| Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives | 1-gen-2023 | Lazzari, Chiara; Spagnolo, Calogera Claudia; Ciappina, Giuliana; Di Pietro, Martina; Squeri, Andrea; Passalacqua, Maria Ilenia; Marchesi, Silvia; Gregorc, Vanesa; Santarpia, Mariacarmela | |
| Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review | 1-gen-2023 | Santarpia, Mariacarmela; Ciappina, Giuliana; Spagnolo, Calogera Claudia; Squeri, Andrea; Passalacqua, Maria Ilenia; Aguilar, Andrés; Gonzalez-Cao, Maria; Giovannetti, Elisa; Silvestris, Nicola; Rosell, Rafael | |
| Therapeutic strategies for HER2-positive breast cancer with central nervous system involvement: a literature review and future perspectives | 1-gen-2023 | Passalacqua, Maria Ilenia; Ciappina, Giuliana; Di Pietro, Martina; Spagnolo, Calogera Claudia; Squeri, Andrea; Granata, Barbara; Muscolino, Paola; Santarpia, Mariacarmela |